223. HIV Prevention 2017
Saturday, October 7, 2017: 10:30 AM-12:00 PM
Room: 14AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the latest approaches to vaccine development for HIV
  • review best practices for increasing the uptake of PrEP in the U.S.
  • discuss prevention strategies effective in Uganda and their applications in the U.S.

Target Audience: Fellows, HIV clinicians, HIV specialists, Infectious diseases physicians, Members-in-training, Pharmacists, Public health practitioners

Tracks: Pediatric ID, HIV-STD-TB, Adult ID, Trainee

Moderators:  Jeanne Marrazzo, MD, MPH, FIDSA, FACP, University of Alabama at Birmingham School of Medicine and Michelle Cespedes, MD, MS, Icahn School of Medicine at Mount Sinai

10:30 AM
HIV Vaccine Update
Paul Goepfert, MD

11:45 AM

CME Credits: Maximum of 1.50 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-309-L01-P


J. Marrazzo, None

M. Cespedes, Gilead Sciences: Scientific Advisor , Consulting fee

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.